Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard T Thaler

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|July 31, 2012
Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgeryDavid Amar, Hao Zhang, Weiji Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neckVolkert B Wreesmann, Weiji Shi, Howard T Thaler, et al.
Journal of Neurochemistry|July 5, 2005
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington diseaseJohn T Pinto, Jeremy M Van Raamsdonk, Blair R Leavitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Early detection and prognosis of ovarian cancer using serum YKL-40Jakob Dupont, Meena K Tanwar, Howard T Thaler, et al.
The Oncologist|August 5, 2015
Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular DysfunctionAnthony F Yu, Nandini U Yadav, Anne A Eaton, et al.
Journal of Pain and Symptom Management|January 10, 2002
The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12John J Collins, Tom D Devine, Gina S Dick, et al.
Cancer Research|October 3, 2002
Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancerLouise R Howe, Kotha Subbaramaiah, Jay Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group studyDavid H Moore, John A Blessing, Richard P McQuellon, et al.
Neoplasia (New York, N.Y.)|September 27, 2015
Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironmentRui V Simões, Inna S Serganova, Natalia Kruchevsky, et al.
Pediatric Blood & Cancer|September 15, 2006
A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignanciesStephen W Gilheeney, David C Lyden, Shirley Sgouros, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Thoracic and Cardiovascular Surgery|July 31, 2012
Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgeryDavid Amar, Hao Zhang, Weiji Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neckVolkert B Wreesmann, Weiji Shi, Howard T Thaler, et al.
Journal of Neurochemistry|July 5, 2005
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington diseaseJohn T Pinto, Jeremy M Van Raamsdonk, Blair R Leavitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Early detection and prognosis of ovarian cancer using serum YKL-40Jakob Dupont, Meena K Tanwar, Howard T Thaler, et al.
The Oncologist|August 5, 2015
Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular DysfunctionAnthony F Yu, Nandini U Yadav, Anne A Eaton, et al.
Journal of Pain and Symptom Management|January 10, 2002
The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12John J Collins, Tom D Devine, Gina S Dick, et al.
Cancer Research|October 3, 2002
Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancerLouise R Howe, Kotha Subbaramaiah, Jay Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group studyDavid H Moore, John A Blessing, Richard P McQuellon, et al.
Neoplasia (New York, N.Y.)|September 27, 2015
Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironmentRui V Simões, Inna S Serganova, Natalia Kruchevsky, et al.
Pediatric Blood & Cancer|September 15, 2006
A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignanciesStephen W Gilheeney, David C Lyden, Shirley Sgouros, et al.
Pageof 8